Mail

UK markets close in 3 hours 15 minutes

FTSE 100
8,210.25
+38.10(+0.47%)
FTSE 250
20,082.09
+29.76(+0.15%)
AIM
770.38
+2.27(+0.30%)
GBP/EUR
1.1682
-0.0001(-0.01%)
GBP/USD
1.2556
+0.0023(+0.19%)
Bitcoin GBP
47,075.44
+251.39(+0.54%)

11 fabulous farmhouses perfect for living a rural lifestyle

A farmhouse could be your dream home if you’re in search of bucolic bliss

TTY Biopharm Company Limited (4105.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD

Add to watchlist

77.60

0.00

(0.00%)

At close: 01:30PM CST

Currency in TWD

Valuation measures⁴

Market cap (intra-day)	19.30B
Enterprise value	18.39B
Trailing P/E	17.13
Forward P/E	16.16
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	3.51
Price/book (mrq)	3.25
Enterprise value/revenue	3.34
Enterprise value/EBITDA	11.11

Trading information

Stock price history

Beta (5Y monthly)	0.24
52-week change ³	0.65%
S&P500 52-week change ³	22.43%
52-week high ³	87.00
52-week low ³	74.60
50-day moving average ³	79.59
200-day moving average ³	79.14

Share statistics

Avg vol (3-month) ³	781.02k
Avg vol (10-day) ³	522k
Shares outstanding ⁵	248.65M
Implied shares outstanding ⁶	248.65M
Float ⁸	196.36M
% held by insiders ¹	19.28%
% held by institutions ¹	15.79%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	3.5
Forward annual dividend yield ⁴	4.51%
Trailing annual dividend rate ³	3.50
Trailing annual dividend yield ³	4.51%
5-year average dividend yield ⁴	4.84
Payout ratio ⁴	75.06%
Dividend date ³	N/A
Ex-dividend date ⁴	28 Mar 2024
Last split factor ²	1067:1000
Last split date ³	13 Aug 2014

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	20.50%
Operating margin (ttm)	17.55%

Management effectiveness

Return on assets (ttm)	8.81%
Return on equity (ttm)	17.56%

Income statement

Revenue (ttm)	5.51B
Revenue per share (ttm)	22.14
Quarterly revenue growth (yoy)	7.30%
Gross profit (ttm)	N/A
EBITDA	1.57B
Net income avi to common (ttm)	1.13B
Diluted EPS (ttm)	4.53
Quarterly earnings growth (yoy)	-16.30%

Balance sheet

Total cash (mrq)	2.82B
Total cash per share (mrq)	11.33
Total debt (mrq)	1.86B
Total debt/equity (mrq)	28.57%
Current ratio (mrq)	2.08
Book value per share (mrq)	23.89

Cash flow statement

Operating cash flow (ttm)	1.09B
Levered free cash flow (ttm)	737.63M